Dr. Akalin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 E 210th St
Montefiore Medical Center
Bronx, NY 10467Phone+1 718-920-4815Fax+1 718-547-4773
Summary
- Dr. Enver Akalin is a nephrologist in Bronx, NY and is affiliated with multiple hospitals in the area, including Montefiore Medical Center and White Plains Hospital Center. He received his medical degree from Ege University Faculty of Medicine and has been in practice 31 years. He is experienced in general nephrology and transplant nephrology. He is currently Professor of Medicine and Surgery at Albert Einstein College of Medicine, Director of Transplant Nephrology fellowship and Medical Director of Kidney and Pancreas Transplant Center at Montefiore Medical Center. His research interest in application of molecular methods to identify mechanisms of chronic allograft injury. He has involved in multicenter trials as a principal investigator and has active multiple NIH grants.
Education & Training
- Emory University School of MedicineFellowship, Nephrology, 1999 - 2000
- Emory University School of MedicineResidency, Internal Medicine, 1997 - 1999
- Boston University Medical CenterFellowship, Nephrology, 1995 - 1996
- Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1993 - 1995
- Ege Univ- Fac MedClass of 1986
Certifications & Licensure
- NY State Medical License 2000 - 2025
Clinical Trials
- Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients Start of enrollment: 2006 Mar 01
- BK Treatment Study Start of enrollment: 2009 Feb 01
- Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation Start of enrollment: 2013 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure.Agathe Truchot, Marc Raynaud, Ilkka Helanterä, Olivier Aubert, Nassim Kamar
Journal of the American Society of Nephrology. 2024-10-16 - Novel Potassium Binders for Early Postoperative Hyperkalemia in Kidney Transplant Recipients: A Single-Center Experience.Alesa Campbell, Weirui Xiao, Enver Akalin, Yorg Azzi, Luz Liriano-Ward
Transplantation Proceedings. 2024-09-01 - 1 citationsSubthreshold rejection activity in many kidney transplants currently classified as having no rejection.Philip F Halloran, Katelynn S Madill-Thomsen, Georg Böhmig, Jonathan Bromberg, Klemens Budde
American Journal of Transplantation. 2024-08-06
Press Mentions
- Dropping Immunosuppression in COVID Has Not Improved Transplant RejectionSeptember 1st, 2022
- Eurofins Transplant Diagnostics Group Receives New York State CLEP Approval for Novel Rejection Biomarker AssaysApril 27th, 2021
- Kidney Transplant Recipients Hard Hit by COVID-19, Study FindsApril 29th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: